Todd M. Brusko, associate professor for UF Department of Pathology, Immunology and Laboratory Medicine, has been named Scientific Director of the UF Diabetes Institute (UFDI). Dr. Brusko joins the senior leadership team of the UFDI under its Director, Mark Atkinson, PhD, Pediatric Medical Director, Desmond Schatz, MD, and…
UFDI investigators and collaborators found that granulocyte colony stimulating factor monotherapy did not affect C-peptide production, HbA1c, or insulin dose.This study supports the continued exploration of G-CSF and other mobilizing agents in subjects with T1D, but only when combined with immunodepleting agents where synergistic mechanisms of action have previously demonstrated…
After isolating and expanding T cells, Dr. Brusko’s lab partnered with biomaterial engineers to create a nanoparticle vaccine to reinvigorate the T cells. Dr. Brusko is highly optimistic.
UF and UF Health faculty, postdoctoral fellows, and graduate students submitted a record number of original research presentations for the American Diabetes Association’s 74th Scientific Sessions held June 13-17, 2014 at the Moscone Center in San Francisco, California. This year's submissions represent one of the largest showcases of research emanating from UF.
Learn about the latest drug-delivery system developed by University of Florida researches that holds the promise for ways to treat and ultimately prevent persons from developing Type 1 Diabetes. The joint effort is bringing research closer to a cure.
In an interview with International Innovation, Todd Brusko, PhD, explains how changes in the field of diabetes research are giving his team of scientists at the UF Diabetes Center of Excellence new opportunities and hope to be able to translate their laboratory findings into clinical treatments. Currently, his team is investigating treatments for type 1 diabetes based on their experiments with regulatory T cells, known as “Tregs.” Learn more.
The Network for Pancreatic Organ Donors with Diabetes (nPOD) program, supported by JDRF at the University of Florida, is the world’s largest open research consortium dedicated to the study of the human pancreas. Founded in 2007, the JDRF nPOD biorepository housed at the University of Florida supports the collection…
